logo
Select company
Select metric
$ 854KCapital Expenditure
VS
Market
70
Sector
44
Industry
27
History
18
$ 8.3Close
$ 6.41 - $ 16.8 52-Week Range
Ticker Information

Ticker

GYRE

Company Name

GYRE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GYRE THERAPEUTICS INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GYRE - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 854K
3/31/2025$ 1.85M
12/31/2024$ 1.91M
9/30/2024$ 9.97M
6/30/2024$ 9.27M
3/31/2024$ 8.03M
12/31/2023$ 7.85M
9/30/2023$ -51K
6/30/2023$ -51K
3/31/2023$ -498K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GYRE THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx stands at $ 227K.
  • Over the past 5 years, GYRE THERAPEUTICS INC's average CapEx has been $ 2.11M.
  • The median CapEx for GYRE THERAPEUTICS INC during this period was $ 710K
  • GYRE THERAPEUTICS INC reached its highest CapEx over the past 5 years at $ 9.97M.
  • The lowest CapEx recorded by GYRE THERAPEUTICS INC in the same timeframe $ -498K

GYRE THERAPEUTICS INC's CapEx vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Benchmarks
CompanyCapEx
PHAT : PHATHOM PHARMACEUTICALS INC $ 164KNAGE : NIAGEN BIOSCIENCE INC $ 257KANAB : ANAPTYSBIO INC $ 372KTBPH : THERAVANCE BIOPHARMA INC $ 239KURGN : UROGEN PHARMA LTD $ 396KCRMD : CORMEDIX INC $ 53.76KNRIX : NURIX THERAPEUTICS INC $ 10.98MZVRA : ZEVRA THERAPEUTICS INC $ 312KKURA : KURA ONCOLOGY INC $ 2.12MSAGE : SAGE THERAPEUTICS INC $ 0

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

GYRE - Capital Expenditure, Last 5 years

$ -498K

Minimum

Dec 31, 2022

$ 9.97M

Maximum

Sep 30, 2024

$ 2.11M

Average

$ 710K

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.66M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.66M
median$ 1.92M
std$ 15.86M